You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
AbbVie Inc. operates through several business segments, primarily focusing on the immunology and oncology therapeutic areas. Major product lines include Humira, Skyrizi, and Rinvoq in the immunology division and Imbruvica and Venclexta in oncology. Additionally, the company has a significant presence in the aesthetics market through its Allergan acquisition, with products like Botox and Juvederm. |
Business Models for Each Product Line |
AbbVie generates revenue predominantly through the sale of prescription medications, relying heavily on its blockbuster drugs like Humira, Skyrizi, and Rinvoq. The company's major expenses include R&D costs for drug development, manufacturing costs, and SG&A expenses related to marketing and administration. The aesthetics division also generates income through direct sales of products and services. |
Future Opportunities for Growth |
AbbVie's growth opportunities lie in expanding the market share of newer immunology drugs like Rinvoq and Skyrizi, as well as advancing its oncology pipeline through innovative therapies. The company also plans to enhance its aesthetics portfolio and geographical expansion, leveraging the Allergan acquisition to capture more global market share. |
Potential Major Risks |
AbbVie faces significant risks from patent expirations, particularly for Humira, which may lead to increased competition from biosimilars. Regulatory scrutiny and pricing pressures in healthcare markets globally can impact profitability. Furthermore, the company’s success heavily depends on its ability to innovate and successfully market new therapeutic solutions. |
Learn More about AbbVie Inc.:
Company Insights by Algobear (ChatGPT);
Tell me more about AbbVie Inc.'s latest earnings (ABBV:Nyse)
Who are some of AbbVie Inc.'s competitors? (ABBV:Nyse)
Are analysts bullish on AbbVie Inc.? Please show it in a table format. (ABBV:Nyse)
Also read:
https://finance.yahoo.com/ABBV/profile
| Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | PEG Ratio (5yr expected) | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 306.02 B | 306020000000.0 | 306.02 | 367.6 B | 367600000000.0 | 367.6 | 72.38 | 14.22 | 0.38 | 5.44 | 92.03 | 6.53 | 24.65 | 7.59% | 36.66% | 8.49% | 62.29% | 56.33 B | 56330000000.0 | 56.33 | 5.60% | 26.72 B | 26720000000.0 | 26.72 | 2.39 | 5.55 B | 5550000000.0 | 5.55 | 68.02 B | 68020000000.0 | 68.02 | 20.2197 | 0.66 | 18.81 B | 18810000000.0 | 18.81 | 19.98 B | 19980000000.0 | 19.98 | 0.10% | 73.82% |
source:https://finance.yahoo.com/ABBV/key-statistics
source:https://www.google.com/finance/quote/ABBV:NYSE
source:https://finance.yahoo.com/ABBV/analysis
source:https://finance.yahoo.com/ABBV/fair-value
source:https://www.nasdaq.com/market-activity/stocks/ABBV/price-earnings-peg-ratios
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|
| Upside % (high) | 9.24% | -2.4% (181.49) | 14.08% (212.15) | 17.58% (218.66) | 17.58% (218.66) | 17.58% (218.66) | 17.58% (218.66) | 17.58% (218.66) |
| Downside % (low) | 12.54% | 9.37% (168.54) | 11.6% (164.39) | 11.6% (164.39) | 11.91% (163.81) | 17.41% (153.58) | 29.58% (130.96) | 75.56% (45.45) |
| Spread % | -3.3% | -11.77% | 2.48% | 5.99% | 5.67% | 0.17% | -11.99% | -57.97% |
ABBV's price used for computing the stats is 185.96 as on date
| Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|
| Last Price-Trend PrevClose | 3.1% | 5.18% | 5.86% | -11.45% | 7.06% | -4.32% | 11.75% | 16.69% | 197.11% |
| Last Price | 185.96 | 185.96 | 185.96 | 185.96 | 185.96 | 185.96 | 185.96 | 185.96 | 185.96 |
| Trend-Previous Close | 180.37 | 176.8 | 175.67 | 210.01 | 173.7 | 194.35 | 166.41 | 159.36 | 62.59 |
ABBV's symbol cumulative return percent is computed basis data from date
| 5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5D window |
5D Opportunity:
SELL-ACTIVE
returns:
5.18%
(3.43%),
p.close: 176.8
entry:
182.87,
exit:
180.41,
min.ret:
1.34%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
5.18%
(2.82%),
p.close: 176.8
entry:
181.78,
exit:
183.33,
min.ret:
-0.85%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
5.18%
(3.3%),
p.close: 176.8
entry:
182.64,
exit:
182.98,
min.ret:
-0.19%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.18%
(6.08%),
p.close: 176.8
entry:
187.55,
exit:
190.16,
min.ret:
-1.4%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.18%
(6.04%),
p.close: 176.8
entry:
187.49,
exit:
190.22,
min.ret:
-1.46%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.18%
(5.5%),
p.close: 176.8
entry:
186.53,
exit:
188.44,
min.ret:
-1.02%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2W window |
2W Opportunity:
SELL-ACTIVE
returns:
5.86%
(3.69%),
p.close: 175.67
entry:
182.16,
exit:
172.41,
min.ret:
5.35%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
5.86%
(3.05%),
p.close: 175.67
entry:
181.02,
exit:
175.54,
min.ret:
3.03%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
5.86%
(9.9%),
p.close: 175.67
entry:
193.06,
exit:
196.64,
min.ret:
-1.86%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
5.86%
(9.13%),
p.close: 175.67
entry:
191.71,
exit:
194.5,
min.ret:
-1.46%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
5.86%
(8.33%),
p.close: 175.67
entry:
190.31,
exit:
192.21,
min.ret:
-1.0%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1M window |
1M Opportunity:
BUY-APPROACHING
returns:
-11.45%
(-23.67%),
p.close: 210.01
entry:
160.3,
exit:
162.39,
min.ret:
1.3%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-11.45%
(-15.16%),
p.close: 210.01
entry:
178.17,
exit:
179.11,
min.ret:
0.52%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-11.45%
(-15.46%),
p.close: 210.01
entry:
177.55,
exit:
179.41,
min.ret:
1.05%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-11.45%
(-12.41%),
p.close: 210.01
entry:
183.96,
exit:
186.26,
min.ret:
1.25%
Using: 1M trend, 0 Days Left
|
ABBV's symbol current price is 185.96 (3.1%) as on . Yesterday's close was 180.37. It's return velocities are computed basis data from date .